Symbolbild · KI-generiert
Spartan Metals Corp.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Spartan Metals is focused on developing critical minerals projects in well-established and stable mining jurisdictions in the Western United States, with an emphasis on building a portfolio of diverse strategic defense minerals such as Tungsten, Rubidium, Antimony, Bismuth, and Arsenic. Spartan's high quality project portfolio includes an option to earn 100% of the Victorio Tungsten-Molybdenum Project in New Mexico and the 100% owned Eagle Tungsten-Silver-Rubidium Project in Nevada. Victorio hosts the largest tungsten resource in the United States and contains significant concentrations of beryllium and fluorspar, while the Eagle Project consists of the highest-grade historic tungsten resource in the USA which includes significant under-defined resources consisting of: high-grade silver; rubidium; antimony; bismuth; indium; as well as precious and base metals, and more information about Spartan Metals can be found at www.SpartanMetals.com.
Company description as published by the issuer via TMX Money.
Comparable companies
Companies in the Defence & Aerospace sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Spartan Metals Corp. | W | TSXV | 21 Mio. USD |
| Reko International Group Inc. | REKO | TSXV | 21 Mio. USD |
| Omni-Lite Industries Canada Inc. | OML | TSXV | 23 Mio. USD |
| Edge Total Intelligence Inc. | CTRL | TSXV | 23 Mio. USD |
| Charbone Corporation | CH | TSXV | 24 Mio. USD |
| Liberty Defense Holdings Ltd. | SCAN | TSXV | 18 Mio. USD |
| Defence Therapeutics Inc | DTC | CSE | 16 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.